China to Get Cut-Price Supplies of GlaxoSmithKline’s New HIV Drug

Glaxosmithkline's New HIV Drug

China to Get Cut-Price Supplies of GlaxoSmithKline’s New HIV Drug

China will get cut-price supplies of GlaxoSmithKline’s new HIV drug Tivicay, after an accord for a Shanghai-based – Desano Pharmaceuticals to turn into an additional manufacturer of the medicine’s active ingredient.

The joint effort between Desano Pharmaceuticals and GSK’s HIV unit ViiV Healthcare marks a change in the business atmosphere for the British drug-producer that was charged a record of a 3 billion Yuan (US$484 million) in September for fixing Chinese doctors.

At that moment, GSK promised to support access to its pharmaceutical locations in the country by growing local production of drugs, and adopting flexible pricing. On the other hand, a ViiV spokesperson said that the transactions with Desano originated before this commitment.

On Thursday, under the agreement declared by ViiV, Desano will manufacture the active pharmaceutical ingredient for dolutegravir, or Tivicay to add into the GSK/ViiV supply chain network for onward sale in China and other developing countries.

ViiV said that the move would permit it to offer a competitive supply of finished products, without determining the scale of price markdown. The spokesman said that the drug’s price in China would be in accordance with that charged in poor countries.

Anna Domanska
Anna Domanska is an Industry Leaders Magazine author possessing wide-range of knowledge for Business News. She is an avid reader and writer of Business and CEO Magazines and a rigorous follower of Business Leaders.

Recent Posts

Ticketing app Dice raises $122 million from SoftBank and ex Apple veteran

Ticketing app Dice raises $122 million from SoftBank and ex Apple veteran

Dice is looking forward to expand more after its latest funding round raised $122 million, led by Tony Fadell.
9 hours ago
The chip shortage is a ‘short-term’ problems, says Elon Musk

The chip shortage is a ‘short-term’ problems, says Elon Musk

The CEO’s outlook is far more optimistic than other automotive industry leaders who believe it may last up to 2023-24.
2 days ago
Supply chain crisis bad news for automotive industry leaders

Supply chain crisis bad news for automotive industry leaders

The world’s biggest car companies are on track to lose production of 7.7 million vehicles in 2021. The forecast advices automakers on supply chain and other issues.
5 days ago
Scammers dupe Apple fans with free bitcoin lure

Scammers dupe Apple fans with free bitcoin lure

Savvy scammers used a fake event stream, a fake Apple website, and the promise of free bitcoin to lure fans into opening up their wallets.
6 days ago
Japan’s MUFG offloads Union Bank to U.S. Bancorp for $7.3 billion

Japan’s MUFG offloads Union Bank to U.S. Bancorp for $7.3 billion

The total amount of cash to be received as part of MUFG Union Bank’s sale to Bancorp is $7.3 billion (800 billion yen).
1 week ago
Evergrande: A black swan event that could spook markets

Evergrande: A black swan event that could spook markets

EverGrande is now known as the “world’s most indebted property developer” and serves as a symbol of corporate excess.
1 week ago